Skip to main content
SpringerLink
Log in

EPA and DHA Possess Different Metabolic Properties

  • Chapter
Current Views of Fatty Acid Oxidation and Ketogenesis

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 466))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Austin, M.A. 1991. Atheroscler. Thromb. 11, 2–14. Plasma triglyceride and coronary heart disease.

    CAS  Google Scholar 

  2. Hodis, H.N., Mack, W.J., Azen, S.P., Alaupovic, P., Pogoda, J.M., LaBree, L, Hemphill, L.C., Kramsch, D.M. & Blankenhorn, D.H. 1994. Circulation, 90, 42–49. Triglyceride-and cholesterol-rich lipoproteins have a different effect on mild/moderate and sereve lesion progression as assayed by quantitative coronary angiography in a controlled trial of lovastatin.

    CAS  PubMed  Google Scholar 

  3. Bang, H.O., Dyerberg, J. & Nielsen, A.B. 1971. Lancet, 710, 1143–1145. Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos.

    Google Scholar 

  4. Nestel, P.J., Connor, W.E., Reardon, M.F., Connor, S.W.S. & Boston, R. 1984. J. Clin. Invest., 74, 82–89. Suppression by diets rich in fish oil of very low density lipoprotein production in man.

    CAS  PubMed  Google Scholar 

  5. Shepherd, J. 1994. Atherosclerosis, 110, S55–S63. The flbrates in clinical practice: focus on micronised fenofibrate.

    Article  CAS  PubMed  Google Scholar 

  6. Staels, B., Vu-Dac, N., Kosykh, V.A., Saladin, R., Fruchart, J.-C, Dallongeville, J. & Auwerx, J. 1995. J. Clin. Invest, 95, 705–712. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomeal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.

    CAS  PubMed  Google Scholar 

  7. Hertz, R., Bishara-Shieban, J. & Bar-Tana, J. 1995. J. Biol. Chem., 270, 13470–13475. Mode of action of peroxisome proliferators as hypolipidemic drugs.

    CAS  PubMed  Google Scholar 

  8. Leaf, A. & Kang, J. 1996. J. Intern. Med., 240, 5–12. Prevention of cardiac sudden death by N-3 fatty acids: a review of the evidence.

    Article  CAS  PubMed  Google Scholar 

  9. Harris, W. 1997. Am. J. Clin. Nutr., 65, 1645S–1654S. n-3 fatty acids and serum lipoproteins: human studies.

    CAS  PubMed  Google Scholar 

  10. Blok, W., Katan, M. & van der Meer, J. W. 1996. J. Nutr., 126, 1515–1533. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids.

    CAS  PubMed  Google Scholar 

  11. Grønn, M., Christensen, E., Hagve, T.A. & Christophersen, B. O. 1992. Biochim. Biophys. Acta, 1125, 35–43. Effects of dietary purified eicosapentaenoic acid (20:5(n-3)) and docosahexaenoicacid (22:6(n-3)) on fatty acid desaturation and oxidation in isolated rat liver cell.

    PubMed  Google Scholar 

  12. Frøyland, L., Vaagenes, H., Asiedu, D., Garras, A., Lie, ø. & Berge, R.K. 1996. Lipids, 31, 169–178. Chronic administration of eicosapentaenoic acid and docosahexaenoic acid as ethyl esters reduced plasma cholesterol and changed the fatty acid composition in rat blood and organs.

    PubMed  Google Scholar 

  13. Von Schacky, C. & Weber, P.C. 1985. J. Clin. Invest., 76, 2446–2450. Metabolism and effects of platlet function of the purified eicosapentaenoic and docosahexaenoic acid in humans.

    Google Scholar 

  14. Berge, R.K. 1993. Omega-3 News, 1, 5–7. The triglyceride-lowering effect of omega-3 fatty acids. Is it all in eicosapentaenoic acid.

    Google Scholar 

  15. Soutar, A. 1978. Nature, 273, 11–12. Does dietary fat influence plasma lipiorotein structure?

    Article  CAS  PubMed  Google Scholar 

  16. Asiedu, D.K., Skorve, J., Willumsen, N., Demoz, A. & Berge, R.K. 1993. Biochim. Biophys. Acta, 1166, 73–76. Early effects on mitochondrial and peroxisomal β-oxidation by the hypolipidemic 3-thia fatty acids in rat livers.

    CAS  PubMed  Google Scholar 

  17. Asiedu, D.K., Demoz, A., Skorve, J., Grav, H.J. & Berge, R.K. 1994. Biochem. Pharmacol., 49, 1013–1022. Acute modulation of rat hepatic lipid metabolism by sulphur-substituted fatty acid analogues.

    Google Scholar 

  18. Skorve, J., Rustan, A.C. & Berge, R.K. 1995. Lipids, 30, 987–994. Effects of non-β-oxidablesulfur-substituted fatty acid analogues on synthesis and secreation of triacylglycerol and cholesterol in cultured rat hepatocytes.

    CAS  PubMed  Google Scholar 

  19. Frøyland, L., Madsen, L., Sjursen, W, Garras, A., Lie, ø., Songstad, J., Rustan, A.C. & Berge, R.K. 1997. J. Lipid Res., 38, 1522–1534. Effect of 3-thia fatty acids on the lipid composition of rat liver, lipoproteins, and heart.

    PubMed  Google Scholar 

  20. Madsen, L., Frøyland, L., Dyrøy, E., Helland, K. & Berge, R.K. 1998. J. Lipid Res., 39, 583–593. Docosahexaenoic-and eicosapentaenoic acid are differently metabolized in rat liver during mitochondria-and peroxisome proliferation.

    CAS  PubMed  Google Scholar 

  21. Lazo, O., Contreras, M., Yoshida, Y., Singh, A.K., Stanley, W., Weise, M. & Singh, I. 1990. J. Lipid Res., 31, 583–595. Cellular oxidation of lignoceric acid is regulated by the subcellular localization of lignoceroyl-CoA ligases.

    CAS  PubMed  Google Scholar 

  22. Willumsen, N., Vaagenes, H., Asiedu, D., Lie, ø., Rustan, A.C. & Berge, R.K. 1996. Lipids, 31, 579–592. Eicosapentaenoic acid but not docosahexaenoic acid (both as ethyl esters) increases mitochondrial fatty acid oxidation and upregulates 2,4-dienoyl-CoA reductase gene expression. A potential mechanism for the hypolipidemic action of fish oil in rats.

    CAS  PubMed  Google Scholar 

  23. Willumsen, N., Hexeberg, S., Skorve, J., Lundquist, M. & Berge, R.K. 1993. J. Lipid Res., 34, 13–22. Docosahexaenoic acid shows no triglyceride-lowering effects but increases the peroxisomal fatty acid oxidation in liver of rats.

    CAS  PubMed  Google Scholar 

  24. Frøyland, L., Madsen, L., Vaagenes, H., Totland, G.K., Auwerx, J., Kryvi, H., Staels, B. & Berge, R.K. 1997. J. Lipid Res., 38, 1851–1858. Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism.

    PubMed  Google Scholar 

  25. Mannaerts, G.P., Debeer, L.J., Thomas, J. & DeShepper, P.J. 1979. J. Biol. Chem., 254, 4585–4595. Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate treated rats.

    CAS  PubMed  Google Scholar 

  26. Asiedu, D.K., Demoz, A., Skorve, J., Grav, H.J. & Berge, R.K. 1995. Biochem. Pharmacol., 49, 4013–1022. Acute modulation of rat hepatic lipid metabolism by sulphur-substituted fatty acid analogues.

    Article  Google Scholar 

  27. Asiedu, D.K., Al-Shurbaji, A., Rustan, A.C., Björkhem, I., Berglund, L. & Berge, R.K. 1995. Em J. Biochem., 227, 715–722. Hepatic fatty acid metabolism as a determinant of plasmaand liver triacylglycerol levels.

    CAS  Google Scholar 

  28. Willumsen, N., Skorve, J., Hexeberg, S., Rustan, A.C. & Berge, R.K. 1993. Lipids, 28, 683–689. The hypotriglyceridemic effect of eicosapentaenoic acid in rats is reflected in increased mitochondrial fatty acid oxidation followed by diminished lipogenesis.

    CAS  PubMed  Google Scholar 

  29. Foreman, B.M., Chen, J. & Evans, R.M. 1996. Ann. N. Y. Acad. Sci, 804, 266–275. The peroxisome proliferatoe activated receptors: ligands and activators.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Biochemistry, University of Bergen Haukeland Hospital, N-5021, Bergen, Norway

    Lise Madsen, Endre Dyrøy & Rolf Berge

Authors
  1. Lise Madsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Endre Dyrøy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rolf Berge
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Unit of Paediatric Surgery Institute of Child Health & Great Ormond Street Hospital for Children NHS Trust, University College London Medical School, London, UK

    Patti A. Quant  & Simon Eaton  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Madsen, L., Dyrøy, E., Berge, R. (2002). EPA and DHA Possess Different Metabolic Properties. In: Quant, P.A., Eaton, S. (eds) Current Views of Fatty Acid Oxidation and Ketogenesis. Advances in Experimental Medicine and Biology, vol 466. Springer, Boston, MA. https://doi.org/10.1007/0-306-46818-2_36

Download citation

  • DOI: https://doi.org/10.1007/0-306-46818-2_36

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46200-9

  • Online ISBN: 978-0-306-46818-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation